Filing Details

Accession Number:
0001127602-13-023714
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-30 11:47:22
Reporting Period:
2013-07-26
Filing Date:
2013-07-30
Accepted Time:
2013-07-30 11:47:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224664 Lawrence Baldini 3471 River Hills Drive
Cincinnati OH 45244
Exec Vp, Operations & Is No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-26 5,250 $0.00 75,250 No 4 M Direct
Common Stock Acquisiton 2013-07-26 10,500 $0.00 85,750 No 4 M Direct
Common Stock Acquisiton 2013-07-26 15,750 $0.00 101,500 No 4 M Direct
Common Stock Acquisiton 2013-07-26 500 $0.00 102,000 No 4 M Direct
Common Stock Disposition 2013-07-26 32,000 $24.14 70,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2013-07-26 5,250 $0.00 5,250 $7.28
Common Stock Stock Options (Right to Buy) Disposition 2013-07-26 10,500 $0.00 10,500 $14.01
Common Stock Stock Options (Right to Buy) Disposition 2013-07-26 15,750 $0.00 15,750 $16.55
Common Stock Stock Options (Right to Buy) Disposition 2013-07-26 500 $0.00 500 $19.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-12-07 No 4 M Direct
0 2015-11-10 No 4 M Direct
0 2016-11-15 No 4 M Direct
500 2020-08-04 No 4 M Direct
Footnotes
  1. Prices range from $24.1044 per share to $24.2401 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
  2. These options became fully vested in November 2008.
  3. These options became fully vested in November 2009.
  4. These options became fully vested in November 2010.
  5. The exercised options vested in August 2011 and Augutst 2012, with the remaining options held scheduled to vest in August 2013 and August 2014.